Zephyrnet Logo

Tag: Biopharma

Nvidia and SandboxAQ collaborate on quantum chemical simulations – Inside Quantum Technology

By Dan O'Shea posted 21 Nov 2023 Nvidia already made a big quantum splash this month with several...

Ault Alliance Announces Notice of Noncompliance with NYSE American Listing Standards – TheNewsCrypto

LAS VEGAS–(BUSINESS WIRE)–$AGREE #AGREE—Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance,” or the “Company”), announced today that on November 13,...

Signal: Dutch health investor Gilde raises $804m for health startup fund

Share this article <!----> Gilde Healthcare, a Dutch health investor, has closed its...

The Weekly Notable Startup Funding Report: 11/13/23

The Weekly Notable Startup Funding Report takes us on a trip across various ecosystems in the US, highlighting some of the notable funding activity...

China Pharmaceutical Competitive Landscape and Drugs Pipeline Analysis Report 2023: Business Overview of 330 Companies, 1500 Drugs in Trials, & 200 Commercially Approved Drugs...

DUBLIN–(BUSINESS WIRE)–The “China Pharmaceutical Companies and Drugs Pipeline Insight 2023” drug pipelines has been added to ResearchAndMarkets.com’s offering. Chinese drugs makers have advanced significantly in...

Bristol Myers’ neuroscience research head explains the big pharma’s return to brain drugs

Like many large pharmaceutical companies, Bristol Myers Squibb hasn’t made brain drugs a top priority over the last decade. As a field, neuroscience represents a...

Big pharma monopolies: major antitrust cases over the past decade

Antitrust laws are put in place to prevent unlawful activities like price fixing, as well as monopolies from forming, typically tied to big pharma....

How biotech IPOs performed in the third quarter

Initial public offerings may slowly be coming back to the biotechnology sector. Eight biotech companies priced IPOs from July through the end of September, raising...

CAR Ts for autoimmune diseases & Hudson’s vision for Sanofi: BioCentury’s latest podcast

Plus: the latest on the Inflation Reduction Act and biotech financings of note By Jeff Cranmer, Executive Editor October 3, 2023 12:44 AM UTC Biopharma...

Maximizing Clinical Development Partnerships: The Power of Authentic Collaboration

Clinical development is a high-stakes endeavor. Companies invest vast resources, both in terms of time and money, to bring new therapies to market. However,...

Emmes Appoints Peter Ronco as Chief Executive Officer

Emmes has announced that Peter Ronco has been named Chief Executive Officer, effective immediately.Ronco succeeds Christine Dingivan, who will serve as a senior advisor...

Phase 1 Human Abuse Liability Studies – BioPharma Services

The Importance of Clinical Trials Well-designed clinical trials pave the way for knowledge and access to new treatments and procedures that can benefit millions around...

Latest Intelligence

spot_img
spot_img